US Broker Ratings

Vericel Corporation (VCEL): Stock Analysis Reveals a Promising 48.89% Upside Potential

Investors in the biotechnology sector may find Vericel Corporation (NASDAQ: VCEL) an intriguing opportunity, as the company presents significant potential upside in its current market position. With a market cap..

NewAmsterdam Pharma (NAMS) Stock Analysis: Healthcare Innovator with 54% Potential Upside

For investors with an eye on the healthcare sector, NewAmsterdam Pharma Company N.V. (NAMS) offers a captivating opportunity. This Netherlands-based biotechnology firm, with a market capitalization of $3.58 billion, is..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Assessing Growth Potential with an 18% Upside

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning player in the biotechnology sector, has been attracting attention with its innovative approach to treating inflammatory diseases. As a clinical-stage biotech company based in..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Exploring a 44% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector with a notable focus on behavioral healthcare services across the U.S. and Puerto Rico. With a market capitalization..

ICU Medical, Inc. (ICUI) Investor Outlook: Analysts Signal a 19.4% Upside Potential

ICU Medical, Inc. (NASDAQ: ICUI) is at the forefront of the healthcare sector, specializing in the production and distribution of innovative medical devices used in infusion therapy, vascular access, and..

Warby Parker Inc. (WRBY) Stock Analysis: A Visionary Growth Story with 15.20% Revenue Surge

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector’s medical instruments and supplies industry, continues to capture investor attention with its innovative approach to eyewear and eye..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Examining the 19% Potential Upside in Biotech Giant

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is making significant strides in the healthcare sector, particularly within the biotechnology industry. With a focus on developing and commercializing treatments for central nervous system..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Gem with 22% Upside Potential

For investors eyeing the healthcare sector, Protagonist Therapeutics, Inc. (PTGX) presents an intriguing opportunity within the biotechnology industry. With a market capitalization of $5.19 billion, the company is making notable..

Sotera Health Company (SHC) Stock Analysis: A Promising 11.68% Potential Upside for Investors

Sotera Health Company (NASDAQ: SHC), a key player in the healthcare diagnostics and research industry, has captured significant attention from investors due to its robust market positioning and promising financial..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Challenges with a 5.24% Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specializes in dental and medical instruments. Despite facing a challenging financial landscape, the company continues to draw investor..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Navigating the 64% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP), a Swiss-based biotechnology firm, is at the forefront of gene editing technology with its innovative CRISPR/Cas9 platform. The company’s focus on developing gene-based medicines for..

Merus N.V. (MRUS) Stock Analysis: Weighing the 7.78% Potential Upside for Investors

Investors with an interest in the biotechnology sector may find Merus N.V. (MRUS) an intriguing consideration, as the company offers a mix of opportunity and challenges, highlighted by its 7.78%..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 158% Upside Potential

Investors eyeing the biotechnology sector may find Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) an intriguing prospect due to its focus on rare and ultra-rare genetic diseases. Headquartered in Novato, California, this..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a 9.95% Potential Upside Amidst Healthcare Sector Challenges

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company headquartered in New York City, is making waves within the healthcare plans industry. With a market capitalization of $4.13 billion, Oscar..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking a 48% Potential Upside

In the dynamic realm of biotechnology, ADMA Biologics Inc (NASDAQ: ADMA) has carved out a niche with its specialty plasma-derived biologics, targeting immune deficiencies and infectious diseases. With a market..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Closer Look at Its 5.38% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a significant player in the biotechnology sector, specifically focusing on the discovery and development of RNA-targeted therapeutics and gene therapies for rare diseases...

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 64.34% Potential Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) is making waves in the healthcare sector with its innovative approach to tackling obstructive sleep apnea (OSA). With a market capitalization of $2.24 billion,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unlocking a Potential 28.25% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, focuses on designing and manufacturing single-use medical products critical for interventional, diagnostic, and therapeutic procedures. With a..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Compelling 190% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing the attention of investors with its remarkable upside potential. As a clinical-stage biopharmaceutical company, Soleno is focused on developing innovative treatments for rare..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Pioneer with 9.82% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology space, has been catching the eye of investors with its innovative approach in diagnostics and research. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds